PMID- 11743038
OWN - NLM
STAT- MEDLINE
DCOM- 20020328
LR  - 20170214
IS  - 0969-1413 (Print)
IS  - 0969-1413 (Linking)
VI  - 8
IP  - 4
DP  - 2001
TI  - Anxiety in a cohort of Swiss women participating in a mammographic screening 
      programme.
PG  - 213-9
AB  - OBJECTIVES: To follow up anxiety in a cohort of women screened for breast cancer. 
      METHODS: Within the framework of a pilot screening programme for breast cancer in 
      the Canton of Vaud (Switzerland), a cohort of 924 participants aged 50-70 years 
      were invited to answer questions on anxiety related to mammography screening. 
      Anxiety was measured using a specific tool, the psychological consequences 
      questionnaire (PCQ), and a new single item, direct question, breast cancer 
      anxiety indicator (BCA). Participants were asked to fill in the questionnaire at 
      four different phases: at screening, before the result, and 2 and 8 weeks after 
      the result. The final response rate was 93.7%. Predictors of anxiety at each 
      phase were assessed using multiple regression. RESULTS: Among those screening 
      negative (94.7%), anxiety at screening was very low and remained so during the 
      screening process. Among those screening false positive, anxiety was 
      significantly higher 8 weeks after having received a negative diagnosis. 
      Predictors of anxiety before screening were lower education and higher age, with 
      a strong exogenous anxiety component. For subsequent phases, the initial anxiety 
      score and education were the main determinants. Furthermore, a false positive 
      result at screening was the most important predictor of anxiety 2 months after 
      negative diagnosis. Anxiety measured with the BCA was strongly correlated with 
      the PCQ. CONCLUSION: Anxiety was very low at screening and remained so during the 
      process for negative women. Initial anxiety level was a strong predictor of 
      anxiety during the entire process, up to 8 weeks after a negative result, and 
      could be easily assessed using the BCA. The sustained higher anxiety level among 
      those screening false positive is an undesirable side effect of the programme.
FAU - Meystre-Agustoni, G
AU  - Meystre-Agustoni G
AD  - Institute of Social and Preventive Medicine (IUMSP), School of Medicine, Bugnon 
      17, University of Lausanne, CH-1005 Lausanne, Switzerland.
FAU - Paccaud, F
AU  - Paccaud F
FAU - Jeannin, A
AU  - Jeannin A
FAU - Dubois-Arber, F
AU  - Dubois-Arber F
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - J Med Screen
JT  - Journal of medical screening
JID - 9433359
SB  - IM
MH  - Aged
MH  - Anxiety/*etiology
MH  - Breast Neoplasms/*diagnostic imaging
MH  - Cohort Studies
MH  - Female
MH  - Humans
MH  - Mammography/*psychology
MH  - Mass Screening/*psychology
MH  - Middle Aged
MH  - Psychological Tests
MH  - Switzerland
EDAT- 2001/12/18 10:00
MHDA- 2002/03/29 10:01
CRDT- 2001/12/18 10:00
PHST- 2001/12/18 10:00 [pubmed]
PHST- 2002/03/29 10:01 [medline]
PHST- 2001/12/18 10:00 [entrez]
AID - 10.1136/jms.8.4.213 [doi]
PST - ppublish
SO  - J Med Screen. 2001;8(4):213-9. doi: 10.1136/jms.8.4.213.